Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KKR vs GSK✓SelectedUSD · GSKKKR vs GSK performance historyLatest closeAs of-0.87%11/18
Stock and ETF performance explorer

KKR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,509.3%
GSK return
+196.6%
Excess return
+1,312.7%
Maximum drawdown
-53.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.9%-1.3%+0.5%-0.3%
7D-6.4%-3.1%-3.2%-5.0%
30D+7.7%-0.9%+8.6%+8.1%
3M-12.6%-4.2%-8.4%-11.1%
6M-2.2%-1.6%-0.6%-2.2%
YTD-26.1%+2.6%-28.7%-28.4%
1Y-17.5%+6.2%-23.7%-21.5%
3Y+42.5%+55.0%-12.5%+5.5%
5Y+24.4%+42.8%-18.5%-5.4%
10Y+605.3%+102.1%+503.2%+317.2%
All+1,509.3%+196.6%+1,312.7%+562.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling